Annual core operating profit increased in 2024 for British pharmaceutical company GSK compared to 2023, the company reported ...

“It brought in new life by introducing a whole new motion design language, emoticons and characters to its logo. It gave meaning ... Take the GSK rebrand in 2022. Ten, or 20 years ago, nobody ...

The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...

GSK (GSK.L, GSK) reported fiscal 2024 profit before tax of 3.5 billion pounds, down 43% at AER, or down 34% at CER from prior year.

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Mr Joshi played a pivotal role in conceptualising BharatPe's entry into consumer businesses launching PostPe and 12% Club ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. GSK’s Beat-and-Raise Results ...